Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $593.1200 (-0.54%) ($593.1200 - $599.9200) on Mon. Aug. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.98% (three month average) | RSI | 41 | Latest Price | $593.1200(-0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -2.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) DIA(36%) IWD(33%) SPLV(33%) SPY(31%) | Factors Impacting REGN price | REGN will decline at least -0.99% in a week (0% probabilities). TBT(-8%) VIXM(-7%) UUP(-5%) VXX(-1%) SHY(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.99% (StdDev 1.98%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $616.79 | 5 Day Moving Average | $599.73(-1.1%) | 10 Day Moving Average | $612.89(-3.23%) | 20 Day Moving Average | $616.79(-3.84%) | To recent high | -10.9% | To recent low | 8.3% | Market Cap | $62.888b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |